Stelmakh Edward (CIK 1887046) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-23). Recent activity: Buy OPRX (5,237 shares), Sell OPRX (1,388 shares), Sell OPRX (3,658 shares), Buy OPRX (5,237 shares), Sell OPRX (1,388 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | Buy | 5,237 | $0 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | Sell | 1,388 | $18,752 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | Sell | 3,658 | $46,603 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | Buy | 5,237 | $0 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | Sell | 1,388 | $18,752 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | Buy | 16,623 | $0 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | Sell | 4,406 | $82,612 |
| 2025-08-25 | OptimizeRx Corp (OPRX) | CFO/COO | Buy | 15,625 | $0 |
| 2025-02-20 | OptimizeRx Corp (OPRX) | CFO/COO | Sell | 2,156 | $14,316 |
Source: SEC Form 4 filings · as of 2025-12-23